Back to Index
Kurt Hong, MD, PhD
Associate Professor of Clinical Medicine
IRD 310 Off Campus Los Angeles
+1 323 226 6571


Dr. Hong's clinical interests are bariatrics/weight management and primary care. His research interests include nutrition medicine and obesity.

Dr. Hong completed his medical degree from Harvard, with a distinction in research. He then went on to complete a Clinical Nutrition Fellowship at UCLA followed by a PhD in Cellular and Molecular Pathology.


University of California, Los Angeles: Undergraduate Teaching Award, 1994

Harvard University Commonwealth Fund: Fellowship in Neuroscience Research, 1996

David Geffen School of Medicine, UCLA: Soloman Scholar, 2005

UCLA Department of Medicine: Research Day Award, 2005

Prostate Cancer Foundation: Young Investigator Award, 2008

Walter J. McKinley Prize for Research and Clinical Investigation

Massachusetts Medical Society: Regents Scholarship, 1999


Hong K, Herrmann K, Dybala C, Halseth AE, Lam H, Foreyt JP. Naltrexone/Bupropion extended release-induced weight loss is independent of nausea in subjects without diabetes. Clin Obes. 2016 Oct; 6(5):305-12. View in: PubMed

Carpenter CL, Yan E, Chen S, Hong K, Arechiga A, Kim WS, Deng M, Li Z, Heber D. Body fat and body-mass index among a multiethnic sample of college-age men and women. J Obes. 2013; 2013:790654. View in: PubMed

Yan E, Chen S, Hong K, Kim WS, Bajpai A, Treyzon L, Gratton L, Elashoff R, Wang HJ, Li Z, Heber D. Insulin, hs-CRP, leptin, and adiponectin. An analysis of their relationship to the metabolic syndrome in an obese population with an elevated waist circumference. Metab Syndr Relat Disord. 2008 Mar; 6(1):64-73. View in: PubMed

Treyzon L, Chen S, Hong K, Yan E, Carpenter CL, Thames G, Bowerman S, Wang HJ, Elashoff R, Li Z. A controlled trial of protein enrichment of meal replacements for weight reduction with retention of lean body mass. Nutr J. 2008; 7:23. View in: PubMed

Hong KM, Belperio JA, Keane MP, Burdick MD, Strieter RM. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem. 2007 Aug 3; 282(31):22910-20. View in: PubMed

Yan E, Durazo F, Tong M, Hong K. Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management. Nutr Rev. 2007 Aug; 65(8 Pt 1):376-84. View in: PubMed

Hong KM, Burdick MD, Phillips RJ, Heber D, Strieter RM. Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice. FASEB J. 2005 Dec; 19(14):2029-31. View in: PubMed

Belperio JA, Keane MP, Burdick MD, Gomperts BN, Xue YY, Hong K, Mestas J, Zisman D, Ardehali A, Saggar R, Lynch JP, Ross DJ, Strieter RM. CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury. J Immunol. 2005 Nov 15; 175(10):6931-9. View in: PubMed

Belperio JA, Keane MP, Burdick MD, Gomperts B, Xue YY, Hong K, Mestas J, Ardehali A, Mehrad B, Saggar R, Lynch JP, Ross DJ, Strieter RM. Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. J Clin Invest. 2005 May; 115(5):1150-62. View in: PubMed

Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004 Aug; 114(3):438-46. View in: PubMed

Li Z, Hong K, Yip I, Huerta S, Bowerman S, Walker J, Wang H, Elashoff R, Go VL, Heber D. Body weight loss with phentermine alone versus phentermine and fenfluramine with very-low-calorie diet in an outpatient obesity management program: a retrospective study. Curr Ther Res Clin Exp. 2003 Jul; 64(7):447-60. View in: PubMed

Powered bySC CTSI